Symbol classroom

ASND

Chart the move, read why OppHub America is covering it, then watch or talk it through — not a Google Finance clone.

ASND

TradingView chart · search any symbol inside the widget · informational only

Live chart & market data via TradingView · OppHub classroom · Delayed or exchange real-time per TradingView data agreements · Not investment advice

0 watching· join free Discuss in Community Join Community

Learn the move

Use this page as a short classroom: (1) scan the chart for the recent move, (2) read OppHub America Insider / Policy / company notes on ASND, (3) note what to watch next, then (4) add ASND to Watch or take the conversation to Community / Club.

Money angle — If Hims & Hers Health capitalizes on its new Eli Lilly tie-up for daily obesity pills and Zepbound, watch for continued commercial momentum; if Liquidia clarifies its $380.7 million settlement funding alongside $222.7 million in preliminary Yutrepia sales, watch execution.

Latest coverage on ASND

Recent OppHub America stories tagged ASND — Insider, Policy, CEO Desk, and market catalysts

ASND Form 4 insiders →ASND policy →CEO Desk →Explore →

StoryNovember 8, 2026

SPDR S&P Biotech ETF·$XBI

$ASND

$TEVA

$UTHR

Biotech Outpaces Major Benchmarks Ahead of Key HIMS & SRRK Earnings

Healthcare equities enter a pivotal earnings and regulatory stretch after outperforming broader market benchmarks during recent sessions. Investors are closely eyeing upcoming updates from Hims & Hers Health (NASDAQ: HIMS), Scholar Rock (NASDAQ: SRRK), and Liquidia (NASDAQ: LQDA) as commercial drug updates and FDA decisions take center stage.

If Hims & Hers Health capitalizes on its new Eli Lilly tie-up for daily obesity pills and Zepbound, watch for continued commercial momentum; if Liquidia clarifies its $380.7 million settlement funding alongside $222.7 million in preliminary Yutrepia sales, watch execution.

Read desk note →Chart SPDR S&P Biotech ETF $XBI

Same-sector peers

Compare nearby names in the classroom

Trade this symbol

End-of-day delayed data · not investment advice · some links are affiliate / referral